Inventories

9 Months Ended

Mar. 31, 2023

Inventories

Inventories

Note 6. Inventories

Inventories at March 31, 2023 and June 30, 2022 consisted of the following:

	March 31,		June 30,
(In thousands)	2023		2022
Raw Materials	$	39,754	$	39,297
Work-in-process		11,759		9,313
Finished Goods		39,292		46,548
Total	$	90,805	$	95,158

During the three months ended March 31, 2023 and 2022, the Company recorded write-downs to net realizable value for excess and obsolete inventory of $0.8 million and $7.4 million, respectively. During the nine months ended March 31, 2023 and 2022, the Company recorded write-downs to net realizable value for excess and obsolete inventory of $4.1 million and $11.4 million, respectively. The write-downs for excess and obsolete inventory for the three and nine months ended March 31, 2022 was higher than the three and nine months ended March 31, 2023 primarily as a result of the discontinuance of two low-margin prescription products manufactured by KUPI in Seymour, Indiana and several products manufactured at the Silarx plant prior to the sale of the facility in Fiscal 2022.